Alterations in the megakaryocyte transcriptome impacts platelet function in sepsis and COVID-19 infection

Abigail Ajanel1, Elizabeth A Middleton2

  • 1Molecular Medicine Program, University of Utah, Salt Lake City, UT 84112, USA; Department of Pathology, University of Utah, Salt Lake City, UT 84112, USA.

Thrombosis Research
|May 31, 2023
PubMed

Insights

Infection alters megakaryocyte (MK) and platelet transcriptomes, impacting immune responses and thrombosis. Understanding these changes is crucial for developing new treatments for severe infections like sepsis and viral diseases.

Area of Science:

  • Hematology
  • Immunology
  • Infectious Diseases

Background:

  • Megakaryocytes (MKs) and platelets play critical roles in infection and inflammation.
  • Infection can alter the transcriptional profiles of MKs and circulating platelets.
  • Altered platelet transcriptomes contribute to pathophysiology, including immunothrombosis.

Purpose of the Study:

  • To explore the impact of altered transcriptomic landscapes in megakaryocytes and platelets during severe systemic infections.
  • To review current literature on the role of MKs and platelets in sepsis and viral infections, including SARS-CoV-2.
  • To highlight how these transcriptomic alterations contribute to thrombotic complications and mortality.

Main Methods:

  • Review of current scientific literature on megakaryopoiesis, thrombopoiesis, and infection.
  • Analysis of studies investigating transcriptomic changes in MKs and platelets during infection.
  • Synthesis of information on the role of platelets in sepsis, viral infections, and immunothrombosis.

Main Results:

  • Infections significantly alter the transcriptional profiles of bone marrow and extra-medullary megakaryocytes and circulating platelets.
  • Altered platelets contribute to pathogen clearance or potentiation of pathophysiology via mechanisms like immunothrombosis.
  • These transcriptomic changes are linked to thrombotic complications, exacerbating organ dysfunction and mortality in severe infections.

Conclusions:

  • Understanding the altered transcriptomic landscape of MKs and platelets during severe infections is vital.
  • Platelet-mediated mechanisms, including immunothrombosis, significantly impact disease severity and outcomes.
  • Targeting these platelet-related pathways holds potential for therapeutic advancements to reduce morbidity and mortality in life-threatening infections.